Estimating the Population Size of People Who Inject Drugs in Malaysia for 2014 and 2017 Using the Benchmark-Multiplier Method

References

• Abdul-Quader, A. S., Baughman, A. L., & Hladik, W. (2014). Estimating the size of key populations: Current status and future possibilities. Current Opinion in HIV and AIDS, 9(2), 107–114. doi:10.1097/COH.0000000000000041
   PubMed Web of Science ®Google Scholar
• Ali, N., Aziz, S. A., Nordin, S., Mi, N. C., Abdullah, N., Paranthaman, V., … Danaee, M. (2018). Evaluation of methadone treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS). Substance Use & Misuse, 53(2), 239–248. doi:10.1080/10826084.2017.1385630
   PubMed Web of Science ®Google Scholar
• Bazazi, A. R., Crawford, F., Zelenev, A., Heimer, R., Kamarulzaman, A., & Altice, F. L. (2015). HIV prevalence among people who inject drugs in Greater Kuala Lumpur recruited using respondent-driven sampling. AIDS and Behavior, 19(12), 2347–2357. doi:10.1007/s10461-015-1191-y
   PubMed Web of Science ®Google Scholar
• Birger, R. B., Le, T., Kouyos, R. D., Grenfell, B. T., & Hallett, T. B. (2017). The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam. PLoS One, 12(5), e0177195. doi:10.1371/journal.pone.0177195
   PubMed Web of Science ®Google Scholar
• Bollaerts, K., Aerts, M., & Sasse, A. (2013). Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000–10. Archives of Public Health, 71(1), 10. doi:10.1186/0778-7367-71-10
   PubMedGoogle Scholar
• Chandrasekaran, S., Kyaw, N. T. T., Harries, A. D., Yee, I. A., Ellan, P., Kurusamy, T., … Suleiman, A. (2017). Enrolment and retention of people who inject drugs in the Needle & Syringe Exchange Programme in Malaysia. Public Health Action, 7(2), 155–160. doi:10.5588/pha.17.0003
   PubMed Web of Science ®Google Scholar
• Fazito, E., Cuchi, P., Mahy, M., & Brown, T. (2012). Analysis of duration of risk behaviour for key populations: A literature review. Sexually Transmitted Infections, 88(Suppl 2), i24–i32. doi:10.1136/sextrans-2012-050647
   PubMedGoogle Scholar
• Gile, K. J., & Handcock, M. S. (2010). Respondent-driven sampling: An assessment of current methodology. Sociological Methodology, 40(1), 285–327. doi:10.1111/j.1467-9531.2010.01223.x
   PubMed Web of Science ®Google Scholar
• Gile, K. J. (2011). Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. Journal of the American Statistical Association, 106(493), 135–146. doi:10.1198/jasa.2011.ap09475
   Web of Science ®Google Scholar
• Girelli, G. (2019). The death penalty for drug offences: Global overview 2018. London: Harm Reduction International.
   Google Scholar
• Hecht, R., Hiebert, L., Spearman, W. C., Sonderup, M. W., Guthrie, T., Hallett, T. B., … Resch, S. (2018). The investment case for hepatitis B and C in South Africa: Adaptation and innovation in policy analysis for disease program scale-up. Health Policy and Planning, 33(4), 528–538. doi:10.1093/heapol/czy018
   PubMed Web of Science ®Google Scholar
• Hickman, M., & Taylor, C. (2005). Indirect methods to estimate prevalence. In Sloboda, Z. (Ed.), Epidemiology of drug abuse (pp. 113–131). Boston: Springer.
   Google Scholar
• Hickman, M., Taylor, C., Chatterjell, A., Degenhardt, L., Frischer, M., & Hay, G. (2002). Estimating the prevalence of problematic drug use: A review of methods and their application. Bulletin on Narcotics, LIV, 15–32.
   Google Scholar
• Hiebert, L., Hecht, R., Soe-Lin, S., Mohamed, R., Shabaruddin, F. H., & Mansor, S. M. S. (2019). A step-wise approach to a national hepatitis C screening strategy in Malaysia to meet the WHO 2030 targets: Proposed strategy, coverage, and costs. Value in Health Regional, 18, 112–120.
   PubMedGoogle Scholar
• IndexMundi. (2018). Malaysia Demographics Profile 2018. Retrieved from https://www.indexmundi.com/malaysia/demographics_profile.html
   Google Scholar
• Larney, S., Grebely, J., Hickman, M., De Angelis, D., Dore, G. J., & Degenhardt, L. (2015). Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs. International Journal of Drug Policy, 26(10), 950–957. doi:10.1016/j.drugpo.2015.07.010
   PubMed Web of Science ®Google Scholar
• Larney, S., Hickman, M., Guy, R., Grebely, J., Dore, G. J., Gray, R. T., … Degenhardt, L. (2017). Estimating the number of people who inject drugs in Australia. BMC Public Health, 17(1), 757. doi:10.1186/s12889-017-4785-7
   PubMedGoogle Scholar
• Lim, A. G., Qureshi, H., Mahmood, H., Hamid, S., Davies, C. F., Trickey, A., … Vickerman, P. (2018). Curbing the hepatitis C virus epidemic in Pakistan: The impact of scaling up treatment and prevention for achieving elimination. International Journal of Epidemiology, 47(2), 550–560. doi:10.1093/ije/dyx270
   PubMed Web of Science ®Google Scholar
• McDonald, S. A., Mohamed, R., Dahlui, M., Naning, H., & Kamarulzaman, A. (2014). Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis. BMC Infectious Diseases, 14(1), 564. doi:10.1186/s12879-014-0564-6
   PubMedGoogle Scholar
• Medhi, G. K., Mahanta, J., Akoijam, B. S., & Adhikary, R. (2012). Size estimation of injecting drug users (IDU) using multiplier method in five districts of India. Substance Abuse Treatment, Prevention, and Policy, 2012(7), 9. doi:10.1186/1747-597X-7-9
   Google Scholar
• Ministry of Health Malaysia. (2012a). Global AIDS Response Country Progress Report Malaysia 2012. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/images/gallery/Report/GLOBAL_AIDS_Endorsed_DG.pdf.
   Google Scholar
• Ministry of Health Malaysia. (2015a). Global AIDS Response and Progress Report, Malaysia. Putrajaya, Malaysia: Author. Retrieved from http://www.unaids.org/sites/default/files/country/documents/MYS_narrative_report_2015.pdf
   Google Scholar
• Ministry of Health Malaysia. (2016). Global AIDS Response Progress Report Malaysia 2016. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/images/gallery/Report/Malaysia%20GARPR%202016_Final.pdf
   Google Scholar
• Ministry of Health Malaysia (HIV/STI Section). (2014). Malaysia 2014 Country Responses to HIV/AIDS: Reporting Period January 2013 to December 2013. Kuala Lumpur, Malaysia: Author.
   Google Scholar
• Ministry of Health Malaysia (HIV/STI Sector). (2012b). Integrated Biological & Behavioral Surveillance Survey (IBBS) 2012. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/index.php
   Google Scholar
• Ministry of Health Malaysia (HIV/STI/Hepatitis C Section). (2015b). Integrated Biological & Behavioral Surveillance Survey (IBBS) 2014 Report. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/index.php
   Google Scholar
• Ministry of Health Malaysia (HIV/STI/Hepatitis C Sector). (2018a). Country Progress Report on HIV/AIDS Malaysia 2018. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/index.php/dl%2F554756755a584a69615852686269394d59584276636d46754c31567464573076556d567762334a3058306442545638794d44453458305a70626d4673587967794b5335775a47593d
   Google Scholar
• Ministry of Health Malaysia (HIV/STI/Hepatitis C Sector). (2018b). Size of key populations in Malaysia: 2018 estimates. Putrajaya, Malaysia: Author. Retrieved from http://www.moh.gov.my/resources/index/Penerbitan/Laporan/PSE_in_Malaysia_2018.pdf
   Google Scholar
• PT Foundation. (2018). HIV/AIDS in Malaysia. Retrieved from http://ptfmalaysia.org/v2/hiv-sti-info/hivaids-in-malaysia/
   Google Scholar
• R Core Team. (2018). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Ramly, M. (2018). Challenges in ending AIDS in Malaysia 2030 (Unpublished presentation). Ministry of Health, Malaysia.
   Google Scholar
• Reid, G., Kamarulzaman, A., & Sran, S. K. (2004). Rapid situation assessment of Malaysia. University Malaya Department of Medicine/Infectious Disease Unit, Kuala Lumpur, Malaysia.
   Google Scholar
• Sweeting, M. J., De Angelis, D., Ades, A. E., & Hickman, M. (2009). Estimating the prevalence of ex-injecting drug use in the population. Statistical Methods in Medical Research, 18(4), 381–395. doi:10.1177/0962280208094704
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UN). (2003). Estimating prevalence: Indirect methods for estimating the size of the drug problem. Global Assessment Programme on Drug Abuse. Toolkit Module 2. Vienna: UNODC.
   Google Scholar
• Vicknasingam, B., Narayanan, S., & Navaratnam, V. (2009). Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Drug and Alcohol Review, 28(4), 447–454. doi:10.1111/j.1465-3362.2009.00087.x
   PubMed Web of Science ®Google Scholar
• Vijay, A., Bazazi, A. R., Yee, I., Kamarulzaman, A., & Altice, F. L. (2015). Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. Journal of Substance Abuse Treatment, 54, 29–36. doi:10.1016/j.jsat.2015.01.014
   PubMed Web of Science ®Google Scholar
• World Bank. (2017). Egypt’s viral hepatitis program; burden and response: An economic analysis. Washington, DC: World Bank.
   Google Scholar
• World Health Organisation (WHO). (2016). Global health sector strategy on viral hepatitis 2016-2021. Geneva: Author.
   Google Scholar